Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study.

By A. Hanley, K. Williams, M. Stern, S. Haffner. Diabetes Care, 2002

671 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Epidemiology

View Paper: https://www.semanticscholar.org/paper/ebafe02da4241f298a56b2925fcabe2162649d35

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Ralph DeFronzo
2. M. Brownlee

In Endocrinology, Diabetes and Metabolism

1. Ralph DeFronzo
2. Z. Bloomgarden
3. G. Hotamışlıgil
4. I. Tabas
5. K. Bornfeldt

In Epidemiology

1. Ralph DeFronzo
2. Z. Bloomgarden
3. G. Hotamışlıgil
4. K. Bornfeldt
5. I. Tabas

Citations in the corpus

• Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009 (2010, methodology): “In the San Antonio Heart Study [67], insulin resistance was quantitated by HOMA of insulin resistance (HOMA-IR) in 2,564 non-diabetic participants who were followed for 8 years.”
• The pathobiology of diabetic complications: a unifying mechanism. (2005, background): “If hyperglycemia is not the major determinant of diabetic macrovascular disease, what about the constellation of risk factors associated with insulin resistance and the metabolic syndrome? In order to separate increased macrovascular disease risk due to insulin resistance and its associated abnormal”
• Inflammation and insulin resistance. (2003, background): “Insulin resistance is associated with increased risk factors (34).”